Pain intensity and pain medication for each pain condition during the 2-week follow-up
| Variable | Renal colic | Abdominal pain | Fracture | Back pain | Neck pain | Musculo-skeletal | Other | Total |
|---|---|---|---|---|---|---|---|---|
| No. of patients | 428 | 166 | 531 | 374 | 65 | 415 | 261 | 2240 |
| Mean ± SD pain intensity at ED discharge, 0–10 scale | 2.5 ± 2.5 | 3.6 ± 2.6 | 5.5 ± 2.4 | 6.0 ± 2.5 | 6.3 ± 2.5 | 5.5 ± 2.5 | 5.4 ± 2.8 | 4.8 ± 2.9 |
| Mean ± SD pain intensity at 14 d, 0–10 scale | 1.0 ± 2.0 | 1.4 ± 2.1 | 3.4 ± 2.2 | 3.6 ± 2.5 | 3.6 ± 2.5 | 3.3 ± 2.6 | 2.3 ± 2.6 | 2.7 ± 2.6 |
| Received acetaminophen prescription at discharge, % | 46.0 | 33.7 | 57.1 | 50.5 | 52.3 | 48.0 | 39.2 | 48.2 |
| Received NSAIDs prescription at discharge, % | 67.5 | 27.7 | 30.7 | 56.4 | 52.3 | 42.4 | 28.5 | 44.4 |
| Filled opioid prescription, % | 92.5 | 86.9 | 93.7 | 94.2 | 89.2 | 93.2 | 91.6 | 92.6 |
| Filled additional opioid prescription, % | 8.5 | 4.6 | 17.5 | 12.1 | 4.9 | 9.7 | 5.6 | 10.8 |
| Median (Q1–Q3) no. of morphine 5 mg tablets prescribed | 16 (12–20) | 15 (10–20) | 16 (12–24) | 17 (12–24) | 18 (11–30) | 16 (10–20) | 15 (10–23) | 16 (10–23) |
| Median (Q1–Q3) no. of morphine 5 mg tablets consumed, 7 d | 2 (0–4) | 2 (0–5) | 7 (2–14) | 7 (2–14) | 6 (3–15) | 5 (1–12) | 3 (0–8) | 4 (1–11) |
| Median (Q1–Q3) no. of morphine 5 mg tablets consumed, 14 d | 2 (0–6) | 2 (0–6) | 9 (2–20) | 8 (3–18) | 6 (2–16) | 6 (2–15) | 4 (1–9) | 5 (1–14) |
| Median (Q1–Q3) no. of morphine 5 mg tablets unused, 14 d | 12 (8–18) | 10 (5–14) | 7 (4–16) | 9 (3–16) | 7 (3–15) | 9 (5–15) | 10 (5–17) | 10 (5–16) |
Note: ED = emergency department, NSAID = nonsteroidal anti-inflammatory drug, Q1–Q3 = first to third quartile, SD = standard deviation.